Regis Healthcare Limited (ASX:REG)
6.97
+0.02 (0.29%)
Mar 2, 2026, 4:11 PM AEST
Regis Healthcare Market Cap
Regis Healthcare has a market cap or net worth of 2.11 billion as of March 2, 2026. Its market cap has increased by 4.41% in one year.
Market Cap
2.11B
Enterprise Value
1.91B
Revenue
1.26B
Ranking
n/a
PE Ratio
55.60
Stock Price
6.97
Market Cap Chart
Since October 7, 2014, Regis Healthcare's market cap has increased from 1.21B to 2.11B, an increase of 74.55%. That is a compound annual growth rate of 5.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.10B | - |
| Dec 31, 2025 | 2.10B | 16.26% |
| Dec 31, 2024 | 1.81B | 84.75% |
| Dec 29, 2023 | 978.36M | 72.49% |
| Dec 30, 2022 | 567.21M | 0.83% |
| Dec 31, 2021 | 562.56M | -1.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 70.65B |
| Sigma Healthcare | 32.66B |
| Pro Medicus | 13.58B |
| Cochlear | 13.01B |
| Telix Pharmaceuticals | 3.39B |
| Mesoblast | 2.89B |
| 4DMedical | 2.29B |
| Neuren Pharmaceuticals | 1.65B |